<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref21">
 <label>21.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Aoyama</surname>  
    <given-names>T</given-names>
   </string-name>, 
   <string-name>
    <surname>Nishikawa</surname>  
    <given-names>K</given-names>
   </string-name>, 
   <string-name>
    <surname>Fujitani</surname>  
    <given-names>K</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>  
  <article-title>Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer</article-title>. 
  <source>Ann Oncol</source>  
  <year>2017</year>;
  <volume>28</volume>:
  <fpage>1876</fpage>–
  <lpage>81</lpage>.
  <pub-id pub-id-type="pmid">28486692</pub-id>
 </mixed-citation>
</ref>
